| AMPK | AMP-activated protein kinase |
| Akt | Protein kinase B |
| BW | Body weight |
| C3G | Cyanidin-3-glucoside |
| DNL | De novo lipogenesis |
| EDL | Extensor digitorum longus |
| FOXO1 | Forkhead box O1 |
| GLUT4 | Glucose transporter type 4 |
| GPCR | G-protein-coupled receptors |
| GPx | Glutathione peroxidase |
| GSK3 | Glycogen Synthase Kinase 3 |
| IL | Interleukin |
| IR | Insulin resistance |
| IRS | Insulin receptor substrates |
| MAPK | Mitogen-activated protein kinase |
| MAFLD | Metabolic dysfunction-associated fatty liver disease |
| mTOR | Mechanistic target of rapamycin |
| NF-κB | Nuclear factor-kappa B |
| PDK1 | Phosphoinositide-dependent kinase 1 |
| PI3K | Phosphoinositide 3-kinase |
| PI3K/Akt | Phosphoinositide 3-kinase/protein kinase B |
| PIP2 | Phosphatidylinositol-4,5-bisphosphate |
| PIP3 | Phosphatidylinositol-3,4,5-trisphosphate |
| Rheb | Ras homolog enriched in the brain |
| ROS | Reactive oxygen species |
| RTK | Receptor tyrosine kinases |
| SGBS | Human Simpson–Golabi–Behmel syndrome |
| SOD | Superoxide dismutase |
| T2D | Type 2 diabetes |
| TNF | Tumor necrosis factor |
| TSC1/2 | Tuberous sclerosis complex 1/2 |
| ULK1 | Unc-51 Like Autophagy Activating Kinase 1 |
| WHO | World Health Organization |